login

Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial

BMJPublished 17 April 1999Open access
Anuja Premawardhena, C E de Silva, M.M.D. Fonseka, Saman B. Gunatilake, H J de Silva
Citations176
View PDF

TL;DR

Use of 0.25 ml of 1:1000 adrenaline given subcutaneously immediately before administration of antivenom serum to patients with envenomation after snake bite reduces the incidence of acute adverse reactions to serum.

Abstract

Use of 0.25 ml of 1:1000 adrenaline given subcutaneously immediately before administration of antivenom serum to patients with envenomation after snake bite reduces the incidence of acute adverse reactions to serum.

Keywords

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyEnvironmental Science